ArticleCurrent oncology (Toronto, Ont.)2024

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Pam Takhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.